{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:18:19Z","timestamp":1793992699297,"version":"4.8.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Guidelines emphasize screening people with elevated BP for the presence of end-organ damage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We characterized the prevalence, correlates, and prognosis of hypertension-mediated organ damage (HMOD) in the community-based Framingham Study. 7898 participants (mean age 51.6 years, 54% women) underwent assessment for the following HMOD: electrocardiographic and echocardiographic left ventricular hypertrophy, abnormal brain imaging findings consistent with vascular injury, increased carotid intima-media thickness, elevated carotid-femoral pulse wave velocity, reduced kidney function, microalbuminuria, and low ankle-brachial index. We characterized HMOD prevalence according to blood pressure (BP) categories defined by four international BP guidelines. Participants were followed up for incidence of cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The prevalence of HMOD varied positively with systolic BP and pulse pressure but negatively with diastolic BP; it increased with age, was similar in both sexes, and varied across BP guidelines based on their thresholds defining hypertension. Among participants with hypertension, elevated carotid-femoral pulse wave velocity was the most prevalent HMOD (40%\u201360%), whereas low ankle-brachial index was the least prevalent (&lt;5%). Left ventricular hypertrophy, reduced kidney function, microalbuminuria, increased carotid intima-media thickness, and abnormal brain imaging findings had an intermediate prevalence (20%\u201340%). HMOD frequently clustered within individuals. On follow-up (median, 14.1 years), there were 384 cardiovascular disease events among 5865 participants with concurrent assessment of left ventricular mass, carotid-femoral pulse wave velocity, kidney function, and microalbuminuria. For every BP category above optimal (referent group), the presence of HMOD increased cardiovascular disease risk compared with its absence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The prevalence of HMOD varies across international BP guidelines based on their different thresholds for defining hypertension. The presence of HMOD confers incremental prognostic information regarding cardiovascular disease risk at every BP category.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/hypertensionaha.121.18502","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T05:01:54Z","timestamp":1638766914000},"page":"505-515","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":126,"title":["Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community"],"prefix":"10.1161","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7357-5970","authenticated-orcid":true,"given":"Ramachandran S.","family":"Vasan","sequence":"first","affiliation":[{"name":"Boston University\u2019s and National Heart, Lung, and Blood Institute\u2019s Framingham Heart Study, Framingham, MA (R.S.V., V.X., A.B.)."},{"name":"Section of Preventive Medicine and Epidemiology, Department of Medicine (R.S.V., V.X.), Boston University School of Medicine, MA."},{"name":"Department of Epidemiology (R.S.V., R.J.S.), Boston University School of Public Health, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Epidemiology (R.S.V., R.J.S.), Boston University School of Public Health, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-621X","authenticated-orcid":true,"given":"Vanessa","family":"Xanthakis","sequence":"additional","affiliation":[{"name":"Boston University\u2019s and National Heart, Lung, and Blood Institute\u2019s Framingham Heart Study, Framingham, MA (R.S.V., V.X., A.B.)."},{"name":"Section of Preventive Medicine and Epidemiology, Department of Medicine (R.S.V., V.X.), Boston University School of Medicine, MA."},{"name":"Department of Biostatistics (V.X., A.B.), Boston University School of Public Health, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8551-7778","authenticated-orcid":true,"given":"Alexa","family":"Beiser","sequence":"additional","affiliation":[{"name":"Boston University\u2019s and National Heart, Lung, and Blood Institute\u2019s Framingham Heart Study, Framingham, MA (R.S.V., V.X., A.B.)."},{"name":"Department of Neurology (A.B.), Boston University School of Medicine, MA."},{"name":"Department of Biostatistics (V.X., A.B.), Boston University School of Public Health, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"DeCarli","sequence":"additional","affiliation":[{"name":"University of California at Davis (C.D.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5643-3145","authenticated-orcid":true,"given":"Gary F.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Cardiovascular Engineering, Inc, Norwood, MA (G.F.M.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudha","family":"Seshadri","sequence":"additional","affiliation":[{"name":"Biggs Institute for Alzheimer\u2019s Disease, University of Texas Health Sciences Center at San Antonio (S.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000107251.49515.c2"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp20X708053"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15026"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.11.006"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/08037051.2020.1735930"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jex094"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp546"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199917070-00016"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19043"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01330-1"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200207000-00017"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2008.56"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.41.3.279"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a112813"},{"key":"e_1_3_2_17_2","first-page":"1077","article-title":"The Sleep Heart Health Study: design, rationale, and methods.","volume":"20","author":"Quan SF","year":"1997","unstructured":"Quan, SF, Howard, BV, Iber, C, Kiley, JP, Nieto, FJ, O\u2019Connor, GT, Rapoport, DM, Redline, S, Robbins, J, Samet, JM, et al. The Sleep Heart Health Study: design, rationale, and methods. Sleep. 1997;20:1077\u20131085.","journal-title":"Sleep"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm021"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv337"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.4.421"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32834fa8b0"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.05.007"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.5.529"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.27.8.1274"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70170-9"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.32765"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2004.05.004"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jev014"},{"key":"e_1_3_2_30_2","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"39","author":"Levey AS","year":"2002","unstructured":"Levey, AS, Coresh, J, Bolton, K, Culleton, B, Harvey, KS, Ikizler, TA, Johnson, CA, Kausz, A, Kimmel, PL, Kusek, J. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1\u2013S266..","journal-title":"Am J Kidney Dis"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40292-019-00345-1"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.886655"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000128420.01881.aa"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.10.4.414"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.989145"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.656744"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.01.008"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.122871"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.7863\/jum.2010.29.12.1759"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2012.08.051"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2004.4064.x"},{"key":"e_1_3_2_42_2","volume-title":"Section 34: Some risk factors related to the annual incidence of cardiovascular disease and death in pooled repeated biennial measurements. Framingham Heart Study, 30 Year Follow-Up","author":"Kannel WB","year":"1987","unstructured":"Kannel, WB, Wolf, PA, Garrison, RJ. Section 34: Some risk factors related to the annual incidence of cardiovascular disease and death in pooled repeated biennial measurements. Framingham Heart Study, 30 Year Follow-Up. US Department of Health and Human Services; 1987."},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpt271"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2005.01.011"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012141"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.06.031"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002705"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000882"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2020.35.e400"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-12-75"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.121.18502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:08:17Z","timestamp":1715580497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.121.18502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.121.18502"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.121.18502","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"2021-10-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}